Module 1: Pathology in Context

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

The primary purpose of this activity is educational and the comments, opinions, and/or recommendations expressed by the faculty or authors are their own and not those of the ASCP. There may be, on occasion, changes in faculty and program content. In order to ensure balance, independence, objectivity, and scientific rigor in all its educational activities, and in accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, the ASCP requires all individuals in positions to influence and/or control the content of ASCP CME activities to disclose whether they do or do not have any financial relationships with ineligible companies¿producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies. These relationships are reviewed and any identified conflicts of interest are mitigated prior to the activity. 

 

The following Pathology Clinics Certificate Program Planning Committee Members and Faculty have no relevant financial relationships with ineligible companies to disclose: 

 

EVENT PLANNING COMMITTEE MEMBERS:  Anne Buckley, MD, PhD, FASCP, Aysegul Sahin, MD, FASCP, Cathryn J. Lapedis, MD, MPH, David Li, MD, FASCP, H. Cliff Sullivan, MD, FASCP, John Groth, MD, Kamran Mirza, MD, PhD, MLS(ASCP), Kene Ojukwu, MD, Lija Joseph, MD, FASCP, Michele Mitchell, MS, PMP, Shuli Waitzman, M(ASCP), Tom Cummings, MD, FASCP

 

The following Event Planning Committee Members and Faculty have disclosed the following relevant financial relationships with ineligible companies. The conflicts were reviewed by members of the Event Planning Committee and underwent mitigation. 

 

PLANNING COMMITTEE 

NAME 

INELIGIBLE COMPANY 

ROLE 

Dr. Jeffrey Myers 

Mediflix 

Consultant 

 

Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence, and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and this input is utilized for subsequent CME planning decisions.